A165T (p.Ala165Thr) variant of PAH (Phenylalanine-4-hydroxylase)
A165T (p.Ala165Thr) in PAH (Phenylalanine-4-hydroxylase) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Phenylketonuria. The available variant effect predictions contribute to a CATVariant prioritization score of 0.90 / 1. The record also includes population frequency data, published literature, and structural context.
A165T (p.Ala165Thr) variant details
- p.Ala165Thr
- rs199475626
- ClinGen CA229579
- ClinVar RCV000088948
- ClinVar RCV000993614
- Likely pathogenic
- Phenylketonuria
- Missense
- Variant Prioritization Score for Impact Estimate 0.901
- REVEL 0.94
- MetaLR 0.99
- MetaSVM 0.96
- CADD 27.60
- PolyPhen-2 0.96
- SIFT 0.01
- ClinVar: Likely pathogenic (Phenylketonuria)
- EBI: Likely pathogenic
- UniProt: Likely pathogenic
- Most common in the Non-Finnish European population (allele frequency 2.9e-05)
- Structural context available
- Cited in: Phenylalanine Hydroxylase Deficiency. (PMID 20301677)
- Cited in: Clinical utility gene card for: Phenylketonuria. (PMID 21915151)